rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Willis C. Lee

CEO

Company insider

Files Form 4 as: CEO, Emmaus Life Sciences; Vice Chairman & COO, Emmaus Life Sciences.

Every Form 4 they filed

In numbers

Trades disclosed
113
Buys
89
Sells
0
Bought
$463K
Sold
$0
Companies
2
Companies where not an officer
0
First trade
5 Oct 2011
Last trade
31 Aug 2026
Last filed
2 Sep 2026

Companies traded

Where they are an officer
Emmaus Life SciencesDirector, Officer · Biotechnology · last 31 Aug 202689 buys · 0 sells
Emmaus Life SciencesDirector, Officer · last 10 May 20160 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
04Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
31 Aug 2026filed 2 Sep 2026Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$5,000100,000 at $0.05filing
31 Aug 2026filed 2 Sep 2026Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$5,000100,000 at $0.05filing
28 Aug 2026filed 2 Sep 2026Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$5,68694,767 at $0.06filing
28 Aug 2026filed 2 Sep 2026Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$5,68694,767 at $0.06filing
27 Aug 2026filed 2 Sep 2026Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$2,50050,000 at $0.05filing
27 Aug 2026filed 2 Sep 2026Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$2,50050,000 at $0.05filing
25 Aug 2026filed 2 Sep 2026Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$1,84046,000 at $0.04filing
25 Aug 2026filed 2 Sep 2026Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$1,84046,000 at $0.04filing
29 Aug 2025filed 2 Sep 2026Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$1,700170,000 at $0.01filing
29 Aug 2025filed 2 Sep 2026Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$1,700170,000 at $0.01filing
30 May 2025filed 2 Sep 2026Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$1,40070,000 at $0.02filing
30 May 2025filed 2 Sep 2026Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$1,40070,000 at $0.02filing
29 Feb 2024filed 29 Feb 2024Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$10K77,000 at $0.13filing
28 Feb 2024filed 29 Feb 2024Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$1,80015,000 at $0.12filing
27 Feb 2024filed 29 Feb 2024Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$1,30010,000 at $0.13filing
26 Feb 2024filed 29 Feb 2024Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$1,58413,200 at $0.12filing
1 Feb 2024filed 5 Feb 2024Emmaus Life Sciencesoption or derivative · BiotechnologySEC FORM 4 Code A$30K200,000 at $0.15filing
30 Nov 2023filed 3 Jan 2024Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$7,12859,400 at $0.12filing
30 Nov 2023filed 4 Dec 2023Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$8907,417 at $0.12filing
29 Nov 2023filed 3 Jan 2024Emmaus Life SciencesBiotechnologySEC FORM 4 Bought$4,32036,000 at $0.12filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care89

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.